1.7400
02-五月-25 15:45:00
15 分钟延时
股票
+0.1100
+6.75%
今日范围
1.6500 - 1.7900
ISIN
N/A
来源
NASDAQ
C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
10 4月 2021 14:05:00 条件 Nasdaq GlobeNewswire